NEXENTIS TECHNOLOGIES INC. Change in Unrealized Gain (Loss) on Foreign Currency Fair Value Hedging Instruments
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Change in Unrealized Gain (Loss) on Foreign Currency Fair Value Hedging Instruments of $41.00 thousand for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:ChangeInUnrealizedGainLossOnForeignCurrencyFairValueHedgingInstruments1 · last filed 2025-08-14
- NEXENTIS TECHNOLOGIES INC. change in unrealized gain (loss) on foreign currency fair value hedging instruments for the quarter ending 2025-06-30 was $41.00K.
- NEXENTIS TECHNOLOGIES INC. change in unrealized gain (loss) on foreign currency fair value hedging instruments for the quarter ending 2025-03-31 was $77.00K.
- NEXENTIS TECHNOLOGIES INC. change in unrealized gain (loss) on foreign currency fair value hedging instruments for fiscal 2024 was $88.00K.
| Period end | Change in Unrealized Gain (Loss) on Foreign Currency Fair Value Hedging Instruments 3 month | Change in Unrealized Gain (Loss) on Foreign Currency Fair Value Hedging Instruments 6 month | Change in Unrealized Gain (Loss) on Foreign Currency Fair Value Hedging Instruments 12 month |
|---|---|---|---|
| 2025-06-30 | $41.00K 10-Q · filed 2025-08-14 | $36.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $77.00K 10-Q · filed 2025-05-15 | ||
| 2024-12-31 | $88.00K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |